BioCentury
ARTICLE | Clinical News

Tadalafil PharmFilm regulatory update

February 8, 2017 10:48 PM UTC

MonoSol said FDA accepted for review an NDA for Tadalafil Oral Soluble Film (OSF) to treat erectile dysfunction (ED). The PDUFA date is Sept. 18. The product is a film formulation of tadalafil, a phos...

BCIQ Company Profiles

Aquestive Therapeutics Inc.

BCIQ Target Profiles

Phosphodiesterase-5 (PDE-5)